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Purpose: The purpose of this study is to investigate whether the microvascular pseudodiffusion
effects resulting with non-monoexponential behavior are present in breast cancer, taking into account
tumor spatial heterogeneity. Additionally, methodological factors affecting the signal in low and high
diffusion-sensitizing gradient ranges were explored in phantom studies.
Methods: The effect of eddy currents and accuracy of b-value determination using a multiple b-value
diffusion-weighted MR imaging sequence were investigated in test objects. Diffusion model selection
and noise were then investigated in volunteers (n= 5) and breast tumor patients (n= 21) using the
Bayesian information criterion.
Results: 54.3% of lesion voxels were best fitted by a monoexponential, 26.2% by a stretched-
exponential, and 19.5% by a biexponential intravoxel incoherent motion (IVIM) model. High
correlation (0.92) was observed between diffusion coefficients calculated using mono- and
stretched-exponential models and moderate (0.59) between monoexponential and IVIM (medians:
0.96/0.84/0.72×10−3 mm2/s, respectively). Distortion due to eddy currents depended on the direction
of the diffusion gradient and displacement varied between 1 and 6 mm for high b-value images. Shift
in the apparent diffusion coefficient due to intrinsic field gradients was compensated for by averaging
diffusion data obtained from opposite directions.
Conclusions: Pseudodiffusion and intravoxel heterogeneity effects were not observed in approx-
imately half of breast cancer and normal tissue voxels. This result indicates that stretched and
IVIM models should be utilized in regional analysis rather than global tumor assessment. Cross
terms between diffusion-sensitization gradients and other imaging or susceptibility-related gradients
are relevant in clinical protocols, supporting the use of geometric averaging of diffusion-weighted
images acquired with diffusion-sensitization gradients in opposite directions. C 2015 Author(s). All
article content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0
Unported License. [http://dx.doi.org/10.1118/1.4927255]
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1. INTRODUCTION
In diffusion-weighted MR imaging (DWI), the exponential
decay of the signal as a function of the diffusion-sensitization
coefficient b is employed to calculate an apparent diffu-
sion coefficient (ADC) for each voxel imaged.1–5 Highly
proliferating malignant tumors result in cell density higher
than normal parenchyma and therefore more restricted water
diffusion. This leads to decreased values of ADC and can
be used for tumor detection, as well as for monitoring and
predicting tumor response.4,5 The signal attenuation, however,
is not only a result of the random microscopic motion
of water molecules influenced by cell density, membrane
integrity, and tissue microstructure but it also depends on
microperfusion and diffusion heterogeneity within a voxel.
As a result, signal behavior cannot always be reliably
described by a simple monoexponential decay and more
complex parametric models are increasingly used.6–13 Ef-
fects associated with microcirculation in capillary networks
and other transport mechanisms can affect the signals in
low b-value images (<200 s/mm2), as described in the
intravoxel incoherent motion (IVIM) model.8–13 Moreover,
in the presence of additional “nondiffusion” field gradients,
such as imaging or susceptibility-related intrinsic gradients,
signal attenuation depends on the square of the sum of
gradients involved. This may lead to a miscalculation of the
diffusion-sensitization coefficient b. In order to exclude such
terms together with additional concomitant fields associated
with the bipolar diffusion encoding, a geometric average of
pairs of images acquired with opposite diffusion gradient
directions and monopolar sequence can be used.14–16 In
addition, eddy currents17 and lower SNR (Refs. 18 and 19)
of high b-value images also compromise the quality of data
fitting.
The purpose of this study was to investigate whether
the microvascular pseudodiffusion effects resulting with non-
monoexponential behavior significantly affect the diffusion-
weighted signals in breast cancer taking into account tumor
spatial heterogeneity. Additionally, methodological factors
affecting the signal in low and high diffusion gradient ranges
were explored in phantom studies. In particular, image distor-
tion due to eddy currents, inaccuracy of b-value determination
due to cross terms between diffusion-sensitizing and imaging
gradients, and noise levels were considered.
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2. METHODS
All imaging was performed on a 3 T MRI scanner (Philips
Achieva, Best, Netherlands) using a dedicated seven-channel
breast coil.
2.A. Multiple b-value DWI protocol
A diffusion-weighted protocol was implemented with ten
b-values and diffusion-sensitization gradients applied in nine
different directions. Pairs of diffusion-sensitization gradients
parallel and antiparallel to imaging gradients directions and at
45◦ to the imaging gradients directions were applied. The
range of b-values employed was from 0 to 1150 s/mm2
(Table I). All diffusion-weighted images were coregistered to
the b= 0 image prior to quantitative analysis using a rigid body
3D transformation available from the manufacturer’s software.
Data were analyzed offline using in-house developed 
software (Mathworks, Cambridge MA).
2.A.1. System characterization
2.A.1.a. Eddy currents. Image distortion was evaluated
using a structured test object (5 mm rods in a 200 mm
diameter cylindrical phantom filled with a solution of 10 mM
CuSO4 in distilled water) by comparing the b= 0 reference
images with diffusion-weighted images acquired sequentially
for three orthogonal diffusion gradient directions (frequency,
phase encoding, and slice imaging). Three angulations (0˚,
15˚, and 30˚) with respect to the sagittal imaging plane were
tested in order to investigate the influence of gradient system
T I. Diffusion-weighted MR imaging protocol parameters used in the
study.
Parameter Value
MRI system 3 T (Philips Achieva, Best,
Netherlands)
Pulse sequence Single shot spin echo EPI
TE/TR (ms) 79/1000
Number of averages 3
FOV (mm) 180
Matrix 192×192
Slice thickness (mm) 3





Phase encode direction Superior to inferior
Receiver bandwidth (Hz/pixel) 2310
b-values (s/mm2) 0, 50, 100, 200, 300, 400, 600, 800,
1000, 1150
Total number and directions of
diffusion-sensitizing gradients
(image coordinate system was used
with M—measurement, P—phase,
and S—slice)
9 (-P/S/-M/P/-S/M /-P > Tra45/
M > Tra45/M > Cor45)
Fat suppression SPAIR
geometry on eddy currents. The centers of the phantom rods
were used to map the distortion by measuring the distances
between the b= 0 and diffusion-weighted images (b= 50, 100,
200, 300, 400, 600, 800, 1000, and 1150).
2.A.1.b. Accuracy of ADC and linearity of diffusion signal
attenuation. Temperature controlled measurements (21 ◦C)
of uniform water and sucrose20 phantoms (200 mm spheres
containing distilled water with the addition of 10 mM
CuSO4 or 500 g/l sucrose, Sigma-Aldrich) were performed to
assess signal attenuation and measured ADC values. A ROI
encompassing 80% of both the water and sucrose spherical
phantoms (central slice) was used to evaluate the calculated
ADC values avoiding partial volume effects.21 ADC values
were first calculated separately for opposite directions of
the diffusion-sensitizing gradients and compared with the
geometrically averaged ADC value.
2.A.2. Clinical studies
Twenty-six women, including 21 with known breast cancer
(median age 52, range: 37–81 yr) and 5 healthy volunteers
(median age 30, range: 28–33 yr) underwent a breast
MRI examination with approval from the Research Ethics
Committee and with written informed consent. Patients with
biopsy-proven breast cancer had only the tumor-containing
breast scanned using the DWI protocol.
2.B. MR imaging protocol
A high resolution T2-weighted TSE VISTA sequence (125
axial slices, 340 mm FOV, TE/TR = 220/2230 ms, and
1.2×1.2×3 mm voxel reconstructed to 0.94×0.94×3 mm)
was acquired initially to plan DWI across the center of the
lesion. Conventional DWI sequence with full breast coverage
was performed first (sagittal SS-EPI, 180 mm FOV, 3 mm
slice thickness, SPAIR and a slice-selection gradient reversal
fat suppression, 4 b-values 0, 350, 750, 1150 mm2/s, TR/TE
= 3771/66 ms, and 1.96×2.02×3 mm voxel) and followed
by the multiple b-value DWI sequence described earlier
(parameters summarized in Table I). Finally, T1-weighted
sequence (sagittal, 3D GRE, TR/TE= 4.5/2.3 ms, FA= 16◦,
180 mm FOV, and 2.37 × 2.4 × 6 mm acquisition voxel
reconstructed to 0.94×0.94×3 mm) with intravenous injection
of 0.2 ml/kg of gadoterate meglumine was used to assist in
the lesion identification and ROI positioning.
In the case of volunteer examinations, both breasts were
scanned using T2-weighted TSE VISTA (full breast coverage)
and multiple b-value DWI sequences (three central slices).
2.C. Image processing and analysis
Regions of interest were drawn manually using postcon-
trast T1-weighted and high b-value images [DWI sequence,
b= 1000 s/mm2, Fig. 1(B)] for tumor and on fat suppressed
T2-weighted b= 0 EPI images for normal parenchyma.
Regions with ADC > 2× 10−3 mm2/s and an absence of
contrast uptake on T1-weighted images (necrotic or cystic
regions) were excluded from the ROIs.22 Parametric maps
Medical Physics, Vol. 42, No. 8, August 2015
4835 Panek et al.: Diffusion models in breast cancer 4835
F. 1. Example of MRI diffusion images [(A) b = 0 s/mm2, (B) b = 1000
s/mm2, and (C) ADC map] of 51 yr-old patient with invasive ductal carci-
noma in the right breast.
of ADC (Refs. 1–5) and SNR (Ref. 23) were calculated pixel
by pixel for ROIs in the tumor and in healthy breast tissue
(patients and volunteers) using .
2.D. Diffusion signal modeling
In this study, three diffusion attenuation models were
considered. The first model assumes a pure diffusion process
and is described by a monoexponential decay of the measured
signal S1 as a function of b-value,
S1(b)= S0e−b ·ADC, (1)
where S0 is the initial signal acquired without diffusion weight-
ing (b= 0) and ADC is the apparent diffusion coefficient. The
second model is described by a stretched-exponential func-
tion.6,7
S2(b)= S0e−b ·DDCα (2)
in which DDC is the distributed diffusion coefficient and α
is the heterogeneity index ranging from 0 to 1. In the case
of homogeneous diffusion α = 1, and the function simplifies
to the monoexponential decay described by the first model.
Lower values of α result either from nonexponential behavior
caused by the addition of proton pools with a range of diffusion
rates within the imaged voxel or from a process where the
motion is intermittent.7 The third model was the biexponential
IVIM model, which accounts for a microcapillary perfusion
and other flow effects contributing to signal attenuation at low
b-values,
S3(b)= S0 · ( f e−b ·D∗+ (1− f )e−b ·D). (3)
This model is parameterized by the pseudodiffusion flow frac-
tion f , the pseudodiffusion rate constant D∗, and the diffusion
rate constant D.8–11 Median ROI values were calculated for
ADC, DDC, and D.
The penalized-likelihood Bayesian information criterion24
(BIC) was used to assess how well each of the three models
is supported by the data (, Econometrics Toolbox),
BIC=−2logL(θ)+ k · log (N), (4)
where L(θ) is the value of the maximized likelihood objective
function for a model with k parameters and N data points.
Given any two estimated models, the model with the lower
value of BIC is the one to be preferred. BIC differences
F. 2. (A) An example of lesion ROI overlaid on an anatomical T2-weighted image. (B) Model selection map showing regions where monoexponential (S1),
stretched-exponential (S2), and biexponential (S3) models were best supported by the data (smallest Bayesian information criterion). (C) An alpha parameter map
for the stretched-exponential model. A high alpha value close to unity shows a preference for the monoexponential model. (D)–(F) Examples of measured signal
(log S) as a function of diffusion weighting (b-values) for voxels with different models selected using BIC [(D) monoexponential, (E) stretched-exponential,
and (F) biexponential IVIM].
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between the models are considered significant, strong, and
very strong for ∆BIC= 2–6, 6–10, and >10, respectively.25
For each voxel, the model with the lowest BIC value
was chosen and displayed in the form of model selection
maps (Fig. 2) and used to calculate overall percentage model
preferences. Correlation between measured ADC, DDC, and
D was measured for all ROI voxels. Correlations between
SNR and BIC values for each model were also used to assess
if the signal to noise levels had an influence on model fitting.
2.E. Statistical analysis
The Wilcoxon signed-rank test26 was used to compare
malignant and healthy tissue diffusion parameters. Kendall’s
tau (τ)27 was used to test for correlations. The null hypothesis
was that there was no correlation between measured param-
eters. The strength of correlation was tested and the values
were considered significant if P < 0.05. Statistical analysis
was performed using the  Statistics Toolbox.
3. RESULTS
Four out of 26 subjects were excluded from the study
because of fat suppression failure.
3.A. Image distortion
The eddy-current-related distortion, in the image phase
encoding direction, was strongly dependent on the direction of
the diffusion gradient (Table II) but not on the imaging plane
angulation between 0◦ and 30◦. The observed image stretch
and displacement varied between 1 and 6 mm.
The sensitization gradient direction resulting in minimum
image misregistration was along the phase-encode imaging
gradient (sagittal: head–feet), corresponding to the z-axis
of the scanner. The largest displacement observed for this
direction in the b-value range between 1000 and 1150 s/mm2
was 2 mm (see Table II). Only the data acquired with the
diffusion-sensitization gradients along the phase encoding
direction (superior–inferior) in the range of 0–800 s/mm2 were
used to model diffusion behavior in order to minimize the
T II. The maximum image misregistration (mm) observed for different
directions of the diffusion gradients in a sagittal breast DWI protocol. Fre-
quency/phase/slice corresponds to y/z/x scanner coordinates in the sagittal
orientation.
Gdiff Frequency Phase Slice
b = 50 1 0 0
b = 100 1 0 0
b = 200 1 0 0
b = 300 2 1 1
b = 400 2 1 1
b = 600 3 1 2
b = 800 3 1 2
b = 1000 4 2 3
b = 1150 6 2 3
F. 3. The b-value dependence on normalized DWI signal for water and
sucrose (500 g/l) at 21 ◦C.
displacement of individual voxels with increasing b-values,
as observed in the phantom work.
3.B. Accuracy and measured ADC values
The signal attenuation as a function of diffusion gradient
b-value in phantoms is monoexponential (Fig. 3) and BICS1
<<BICS2,3.
ADC values measured with no geometric averaging depend
on the direction of the diffusion gradient used [Fig. 4(A)].
With the diffusion gradient parallel and antiparallel to
the phase encoding direction, the median ADC values were
2.17 and 2.2± 0.02× 10−3 mm2/s and 0.72 and 0.75± 0.03
× 10−3 mm2/s for the water and sucrose phantoms, respec-
tively. ADC values measured using geometrically averaged
pairs of images (opposite diffusion gradient directions)
differed statistically from nonaveraged values (p < 0.05) and
these values were 2.18±0.02×10−3 mm2/s and 0.74±0.02
×10−3 mm2/s for water and sucrose, respectively [Fig. 4(B)].
Figure 1 shows a clinical example of low [Fig. 1(A)]
and high [Fig. 1(B)] b-value DWI-EPI images (multiple
F. 4. Histograms of ADC values for diffusion-sensitization gradient in two
opposite directions (plus and minus) measured for water (21 ◦C) (A) and a
histogram for geometrically averaged data (B).
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F. 5. A comparison of patient median ADC, DDC, and D in malignant and
normal breast tissue. All diffusion coefficients were significantly higher in the
normal tissue than in malignant lesions (PS1−3 < 0.001).
b-value sequence). ADC values [Fig. 1(C)] obtained from
ROIs in normal breast tissue were significantly higher than
in malignant lesions (P < 0.001). The median ADC value for
the parenchyma was 1.76×10−3 and 0.96×10−3 mm2/s for
breast cancer (Fig. 5).
3.C. Noise
The SNR distribution calculated for breast ROIs at the b-
value 800 s/mm2 was positively skewed with median values of
10.09 in tumor and 2.18 in the normal breast tissue. There was
no correlation between SNR and the BIC values calculated for
the models used (tumor: τS1 = 0.05, τS2 = −0.03, τS3 = 0.07
and parenchyma: τS1= 0.03, τS2= 0.08, τS3= 0.11).
3.D. Model selection
A high correlation was observed between diffusion coef-
ficients calculated using mono- and stretched-exponential
models (τtumor = 0.92, τparenchyma = 0.9). A moderate correla-
tion was found between the monoexponential model and IVIM
(τtumor = 0.59, τparenchyma = 0.53). Median values were 0.96,
0.84, and 0.72×10−3 mm2/s for ADC (S1), DDC (S2), and D
(S3), respectively, in tumor and 1.76, 1.75, and 1.24 ×10−3
mm2/s in normal breast parenchyma (Fig. 5). All diffusion
coefficients were significantly higher in the normal tissue than
in malignant lesions (PS1−3 < 0.001). The Bayesian informa-
tion criteria from the lesion ROI data showed that 54.3% of
voxels were best fitted by the monoexponential, 26.2% by
the stretched-exponential, and 19.5% by the biexponential
IVIM model (Nvoxels = 4601). In 83% of voxels, the BIC
difference between the models was considered significant25
with 66% positive, 9% strong, and 8% very strong evidence.
Figure 2 shows an example of a model selection map and
the corresponding alpha parameter map. The distribution of
the stretched-exponential alpha parameter in the tumor is
negatively skewed (γ1 = −0.9) with a median value of αtumor
= 0.75, the pseudodiffusion rate constant D∗tumor= 21.5×10−3
mm2/s, and the pseudodiffusion flow fraction f tumor= 0.15.
In the normal parenchyma, 58.3% of voxels were best fitted
by the monoexponential, 24.6% by the stretched-exponential,
and 17.1% by the biexponential IVIM model (Nvoxels= 5022).
In 83% of voxels, the BIC difference between the models
was considered significant with 68% positive, 8% strong, and
7% very strong evidence. The distribution of the stretched-
exponential alpha parameter in the parenchyma is negatively
skewed (γ1=−0.92) with a median value of αparenchyma= 0.8,
the pseudodiffusion rate constant D∗parenchyma = 16.8× 10−3
mm2/s, and the pseudodiffusion flow fraction fparenchyma
= 0.08.
4. DISCUSSION
Diffusion-weighted imaging is increasingly being used
for cancer detection and diagnosis. However, it is still an
open question as to which models are appropriate for DWI
in various body regions and cancer types characterized by
different microscopic environments.
Initial implementations of IVIM in the breast have been
reported indicating the feasibility of perfusion fraction and
pseudodiffusion coefficient measurements13 in addition to the
diffusion coefficient. A biexponential characterization of the
diffusion attenuation signal has been reported for lesions, in
contrast to a monoexponential dependence in normal tissue.
These measurements were performed using the mean signal
over ROIs and therefore disregard lesion heterogeneity, which
is clearly observed in practice (Fig. 1). It has also been shown
that the diffusion attenuation is no longer monoexponential
at large b-values (b > 2000 s/mm2)28–32 including breast
cancer preclinical studies,33–35 and this effect is associated
with restricted intracellular water diffusion rather than the
properties of restricting boundaries in the extracellular space.
Another confounding factor is fat signal, which depends on
the choice of fat suppression technique, especially relevant
in the case of higher b-value (>600 s/mm2) breast DWI
images.36 Although clinical systems are increasingly capable
of delivering higher b-values, it is likely that noise will
dominate breast images acquired with clinical parameters and
b > 2000 s/mm2. Another concern is an assumption of the
IVIM model, which states that time after diffusing particles
change their direction is several times shorter than the total
duration of diffusion gradients (i.e., 7 times–Le Bihan9). A
recent study shows that this assumption is not met in liver and
pancreas,16 suggesting that a further development is needed to
appropriately calculate pseudodiffusion coefficient D∗. There
is, however, lack of evidence for similar shortcomings in breast
parenchyma and lesions.
One of the methodological DWI caveats which is also a
potential limitation of this work is a choice of b-values, which
affects calculated diffusion coefficient values. The range of b-
values used should be adjusted for expected diffusion values in
the examined tissues, observed SNR levels, and eddy currents.
b-values in the range of 0–800 s/mm2 are commonly used in
the breast and IVIM applications.11–13
In our work, the diffusion signal was analyzed for each
pixel of ROIs defined in test objects, lesions, and normal
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tissue. Test object images acquired with diffusion-sensitization
gradients of opposite polarity produced significantly different
ADC values, suggesting that other gradients contribute toward
diffusion weighting. This highlights an essential issue in
modeling diffusion behavior: cross terms between diffusion-
sensitization gradients and other gradients were shown to
be relevant (Fig. 4) and may induce error. In this work,
geometrical averaging of images produced with diffusion-
sensitization gradients of opposite polarity was used to mini-
mize the effect of other gradients in order not to compromise
the accuracy of the modeling. In addition, phantom work
showed that geometrical distortion of high b-value images is
significant (Table II) and can introduce errors in the ADC
evaluation. In this work, only the data acquired with the
diffusion-sensitization gradients along the phase encoding
direction (superior–inferior) in the 0–800 s/mm2 b-value range
were used to model diffusion behavior, minimizing the error.
Other practical solutions to reduce eddy current distortion
are to use the bipolar diffusion gradient scheme;15 however,
the use of temporally asymmetric diffusion gradients leads to
the presence of significant concomitant fields and undesired
signal voids.15,16
Statistical model selection analysis suggests that the
monoexponential model describes majority of the data most
accurately. There was, however, evidence of regions with
signal best described by stretched-exponential and IVIM
models in both tumor and normal breast tissue. This might
suggest a presence of increased structural heterogeneity or
microperfusion and might be of clinical use. The parameter
alpha may be used to identify regions showing significantly
non-monoexponential behavior [lower alpha, Figs. 2(B) and
2(C)]. Median diffusion coefficients calculated using all
three models show significant differences between tumor
and normal breast parenchyma. Data distribution representing
intratumoral heterogeneity (Fig. 5) reveals greater overlap
between malignant and normal tissues in the case of IVIM
model. The median IVIM diffusion coefficients are markedly
lower than the analogous parameters from other models. This
could be a consequence of a signal fit bias for smaller b-values
in the presence of pseudodiffusion and as a result higher DDC
and ADC values.37
An important feature of the Bayesian information criterion
is that more complex models are appropriately penalized
relative to simpler models that fit the data equally well, given
the data SNR.24 Correlations are not observed between the
SNR and the penalized-likelihood BIC for the models consid-
ered. This indicates the preference for stretched-exponential
model is unrelated to noise levels. In the case of insufficient
SNR, a pure diffusion process characterized correctly by a
monoexponential decay would appear artificially stretched in
the higher b-value region due to a noise-floor effect, which
would lead to a correlation between SNR and BIC values.
5. CONCLUSIONS
Cross terms between diffusion-sensitization gradients and
other gradients (either imaging gradients or susceptibility-
related gradients) are relevant in clinical protocols, supporting
the use of geometric averaging of diffusion-weighted images
acquired with diffusion-sensitization gradients in opposite
directions. Microcirculatory pseudodiffusion and intravoxel
heterogeneity effects were not observed in approximately half
of normal and malignant breast tissue. This result indicates
that stretched and IVIM models should be utilized in local
voxel analysis rather than global tumor assessment.
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